Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  HIV Infection

  Free Subscription

Articles published in J Clin Invest

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    November 2021
  1. SCULLY EP, Bryson BD
    Unlocking the complexity of HIV and Mycobacterium tuberculosis coinfection.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

  2. MITCHELL JL, Pollara J, Dietze K, Edwards RW, et al
    Anti-HIV antibody development up to one year after antiretroviral therapy initiation in acute HIV infection.
    J Clin Invest. 2021 Nov 11. pii: 150937. doi: 10.1172/JCI150937.
    PubMed     Abstract available

    October 2021
  3. LI M, Garforth SJ, O'Connor KE, Su H, et al
    T-cell receptor-specific immunotherapeutics drive selective in vivo HIV and CMV-specific T-cell expansion in humanized mice.
    J Clin Invest. 2021 Oct 21. pii: 141051. doi: 10.1172/JCI141051.
    PubMed     Abstract available

    HIV-specific CAR T cells return to the clinic.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

    September 2021
    Forty years of AIDS: a retrospective and the way forward.
    J Clin Invest. 2021;131.

  6. CORREA-MACEDO W, Fava VM, Orlova M, Cassart P, et al
    Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosis.
    J Clin Invest. 2021 Sep 2. pii: e148013. doi: 10.1172/JCI148013.
    PubMed     Abstract available

  7. DIAS J, Fabozzi G, March K, Asokan M, et al
    Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

    August 2021
  8. LIU B, Zhang W, Xia B, Jing S, et al
    Broadly neutralizing antibody-derived CAR-T cells reduce viral reservoir in HIV-1-infected individuals.
    J Clin Invest. 2021 Aug 10. pii: e150211. doi: 10.1172/JCI150211.
    PubMed     Abstract available

  9. MENDEZ-LAGARES G, Chin N, Chang WLW, Lee J, et al
    Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

    July 2021
  10. BANSAL A, Gehre MN, Qin K, Sterrett S, et al
    HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.
    J Clin Invest. 2021 Jul 6. pii: e148979. doi: 10.1172/JCI148979.
    PubMed     Abstract available

    June 2021
  11. ASTRONOMO RD, Lemos MP, Narpala SR, Czartoski J, et al
    Rectal and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.
    J Clin Invest. 2021 Jun 24. pii: e146975. doi: 10.1172/JCI146975.
    PubMed     Abstract available

  12. REICHMANN MT, Tezera LB, Vallejo AF, Vukmirovic M, et al
    Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies therapeutic targets.
    J Clin Invest. 2021 Jun 15. pii: e148136. doi: 10.1172/JCI148136.
    PubMed     Abstract available

  13. DUFOUR C, Gantner P, Fromentin R, Chomont N, et al
    The multifaceted nature of HIV latency.
    J Clin Invest. 2021;131.

  14. LI JZ, Blankson JN
    How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

    May 2021
  15. RIOU C, Du Bruyn E, Stek C, Daroowala R, et al
    Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and Tuberculosis co-infection.
    J Clin Invest. 2021 May 4. pii: 149125. doi: 10.1172/JCI149125.
    PubMed     Abstract available

  16. HARTANA CA, Rassadkina Y, Gao C, Martin-Gayo E, et al
    Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

    March 2021
  17. ZHANG C, Song JW, Huang HH, Fan X, et al
    NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

    February 2021
  18. OKOYE AA, Duell DD, Fukazawa Y, Varco-Merth B, et al
    CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.
    J Clin Invest. 2021 Feb 25. pii: 141677. doi: 10.1172/JCI141677.
    PubMed     Abstract available

  19. SAFER JD
    Research gaps in medical treatment of transgender/nonbinary people.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

  20. TEBAS P, Jadlowsky JK, Shaw PA, Tian L, et al
    CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication.
    J Clin Invest. 2021 Feb 11. pii: 144486. doi: 10.1172/JCI144486.
    PubMed     Abstract available

  21. MATSUDA K, Migueles SA, Huang J, Bolkhovitinov L, et al
    A replication competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.
    J Clin Invest. 2021 Feb 2. pii: 140794. doi: 10.1172/JCI140794.
    PubMed     Abstract available

    January 2021
  22. SWANSTROM AE, Immonen TT, Oswald K, Pyle C, et al
    Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy.
    J Clin Invest. 2021 Jan 19. pii: 142421. doi: 10.1172/JCI142421.
    PubMed     Abstract available

    December 2020
  23. SIMONETTI FR, Zhang H, Soroosh GP, Duan J, et al
    Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo.
    J Clin Invest. 2020 Dec 10. pii: 145254. doi: 10.1172/JCI145254.
    PubMed     Abstract available

  24. PILLAY BA, Fusaro M, Gray PE, Statham AL, et al
    Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency.
    J Clin Invest. 2020 Dec 8. pii: 142434. doi: 10.1172/JCI142434.
    PubMed     Abstract available

    October 2020
  25. HALVAS EK, Joseph KW, Brandt LD, Guo S, et al
    HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus.
    J Clin Invest. 2020 Oct 5. pii: 138099. doi: 10.1172/JCI138099.
    PubMed     Abstract available

  26. SILICIANO JD, Siliciano RF
    Nonsuppressible HIV-1 viremia: a reflection of how the reservoir persists.
    J Clin Invest. 2020 Oct 5. pii: 141497. doi: 10.1172/JCI141497.
    PubMed     Abstract available

  27. PEREZ-DIEZ A, Wong CS, Liu X, Mystakelis H, et al
    Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia.
    J Clin Invest. 2020;130:5326-5337.
    PubMed     Abstract available

    September 2020
  28. IGNATIUS EH, Cohen KA, Bishai WR
    Getting to the point in point-of-care diagnostics for tuberculosis.
    J Clin Invest. 2020 Sep 28. pii: 142497. doi: 10.1172/JCI142497.
    PubMed     Abstract available

  29. DUKE ER, Williamson BD, Borate B, Golob JL, et al
    Cytomegalovirus viral load kinetics as surrogate endpoints after allogeneic transplantation.
    J Clin Invest. 2020 Sep 24. pii: 133960. doi: 10.1172/JCI133960.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.